Migraine Drugs During Pregnancy Pose Risk to Baby's IQ

Tuesday, 07 May 2013 07:58 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. health regulators are warning doctors and women of child-bearing age that half-dozen medications used to treat migraine headaches can decrease children's intelligence if taken while their mothers are pregnant.
 
The Food and Drug Administration said Monday that the drugs, including Depakote and Depacon, should never be taken by pregnant women for the prevention of migraine headaches.
 
The pills, which all contain the ingredient valproate sodium, already carry a boxed warning about the risk of birth defects. But the FDA said it is adding new warnings to the drugs after a study showed they decreased IQ scores in children whose mothers took them while pregnant.
 
"We have even more data now that show the risks to the children outweigh any treatment benefits for this use," said Russell Katz, the FDA's director for neurology drugs.
 
Earlier this year, researchers at Emory University reported that valproate-containing drugs were connected with an 8 to 11 point reduction in IQ scores for children at age 6. The study compared children whose mothers had taken different classes of neurological drugs while pregnant. The results supported similar findings from when the children were age 3.
 
Depakote and similar drugs are also used to treat bipolar disorder and seizures. While the FDA said it would not contraindicate the drugs for those uses, the agency said women of child-bearing age should only them as a last resort.
 
"Women who can become pregnant should not use valproate unless it is essential to managing their medical condition," the agency said in a statement.
 
Depakote is marketed in the U.S. by AbbVie, which was spun off earlier this year from parent company Abbott Laboratories. AbbVie also markets several other versions of the drug, including Depacon, an injectable formulation. The FDA's warning also affects Stavzor, a pill marketed by Noven Pharmaceuticals for bipolar disorder.
 
The FDA said it is working with the drug manufacturers to change their products' pregnancy code for migraines to X. The code indicates that the drug's risks outweigh its benefits for the given use.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Favorite Easter Candy: What Will It Take to Work It Off?

Friday, 18 Apr 2014 16:37 PM

Marshmallow Peeps, Cadbury Crème Eggs, and chocolate bunnies are popular for Easter. But what will it take to burn off t . . .

Weight Surgery Changes Sense of Taste, Researchers Find

Friday, 18 Apr 2014 16:34 PM

After weight-loss surgery, many patients report changes in appetite, taste and smell, a new study says. One positive as . . .

PTSD Sufferers Get Fast Relief From Ketamine: Study

Friday, 18 Apr 2014 16:31 PM

Ketamine has been shown to reduce moderate to severe symptoms of post-traumatic stress disorder (PTSD), researchers have . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved